サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514977

ワクチン受託製造市場：ワクチンタイプ別、製品タイプ別、用途別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測

Vaccine Contract Manufacturing Market, By Vaccine Type, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 265 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ワクチン受託製造市場：ワクチンタイプ別、製品タイプ別、用途別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 265 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ワクチン受託製造市場規模は2023年に29億10万米ドルとなり、2024～2032年にかけてCAGR 8.00%で拡大

ワクチン受託製造市場-市場力学

ワクチン需要の増加とバイオテクノロジー産業が市場需要を促進する見込み

ワクチン接種プログラムの拡大、感染症の流行増加、新興病原体と闘うための新しいワクチンの必要性により、ワクチンに対する世界の需要は増加し続けています。このような需要により、製薬会社は効率的に生産規模を拡大するために製造委託先を求めています。ワクチン製造には多くの場合、特殊な施設、技術、専門知識が必要とされます。ワクチン製造に定評のある受託製造業者は効率的なソリューションを提供できるため、製薬会社は研究開発・販売に専念することができます。このように、研究と技術の進歩は市場成長において重要な役割を果たしています。

ワクチン製造は、FDAやEMAを含む世界中の保健当局によって高度に規制されています。規制遵守の専門知識を確立した受託製造業者は、承認プロセスを迅速化し、品質基準の遵守を保証することで、新規ワクチンの市場投入までの時間を短縮することができます。多くの製薬会社は、社内製造能力の限界に直面しているかもしれません。受託製造業者は、変動する需要に対応し、世界にワクチンを供給するための追加能力、柔軟性、拡大性を記載しています。そのため、製造能力を強化するために、ワクチン受託製造は需要の変化とともに市場の成長を補完しています。

ワクチン受託製造市場-主要洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約8.00%のCAGRで毎年成長すると推定されます。

ワクチンタイプ別セグメンテーションによると、ウイルス性疾患の高い流行に起因して、弱毒性セグメントが2023年に最大の市場シェアを示すと予測されました。

製品タイプ別では、一価ワクチンの比率が高いことから、2023年には一価ワクチン市場が最大シェアを占めると予測されます。

用途別セグメントでは、ヒトの間でのワクチン接種需要の高まりにより、ヒト用セグメントが2023年の主要用途でした。

エンドユーザーセグメント別では、製薬会社セグメントが2023年の主要エンドユーザーでした。

地域別では、北米が2023年の主要収益源であり、これは市場上位企業の存在によるものです。

ワクチン受託製造市場-セグメンテーション分析：

世界のワクチン受託製造市場は、ワクチンタイプ、製品タイプ、用途、エンドユーザー、地域によって区分されます。

ワクチンは弱毒ワクチン、不活化ワクチン、DNAベースワクチン、トキソイドベースの4種類に分類されます。弱毒ワクチンセグメントが市場を独占しています。ウイルス感染に対する高い需要が弱毒ワクチンの需要を押し上げています。

市場は製品タイプにより、単独ワクチンと混合ワクチンの2つに分類されます。単一ワクチンが市場を独占しています。予測期間中は、混合ワクチンが最も高い成長率を示すと予測されます。

市場は用途により、ヒト用と動物用の2つに分類されます。ヒト用セグメントが市場を独占しています。ウイルス性疾患や重篤な疾患の予防や予備免疫を目的とした人間へのワクチン接種ニーズの高まりが、同セグメントの需要を拡大しています。

市場はエンドユーザー別にバイオ製薬会社、研究所、その他の3つに分類されます。バイオ製薬企業が市場を独占しており、予測期間中も高い優位性を維持すると予想されます。バイオ医薬品企業におけるワクチンのニーズと製造数の増加が市場成長を促進しています。

ワクチン受託製造市場-地域別洞察

ワクチン受託製造市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。アジア太平洋では、製造コストの低下、バイオ医薬品産業の成長、医療インフラへの投資の増加などを背景に、ワクチン受託製造が急成長しています。インドや中国のような国々は、費用対効果の高い製造と大規模生産能力という競合優位性を提供し、世界のワクチンサプライチェーンにおける重要な参入企業になりつつあります。

ワクチン受託製造市場-競合情勢：

ワクチン受託製造市場は、少数の主要企業による厳しい競争が特徴です。市場を独占しているのは、Lonza、Catalent、Samsung Biologicsなどの著名な受託製造企業（CMO）です。ワクチン受託製造市場におけるこれらの企業は、需要の増加に対応するため、生産能力を継続的に拡大しています。各社はワクチンの生産効率と収率を向上させるため、先進的なバイオテクノロジー・プラットフォームや製造技術に投資しています。

目次

第1章 ワクチン受託製造市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブ概要

  • 市場内訳
  • 競合考察

第3章 ワクチン受託製造の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ワクチン受託製造業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 ワクチン受託製造市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 ワクチン受託製造市場情勢

  • ワクチン受託製造市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ワクチン受託製造市場-ワクチンタイプ別

  • 概要
    • ワクチンタイプ別セグメントシェア分析
    • 弱毒化
    • 不活化
    • DNAベース
    • トキソイドベース

第8章 ワクチン受託製造市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 単一ワクチン
    • 混合ワクチン

第9章 ワクチン受託製造市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • ヒト用
    • 動物用

第10章 ワクチン受託製造市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • バイオ製薬会社
    • 研究所
    • その他

第11章 ワクチン受託製造市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-ワクチン受託製造業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Lonza Group
    • Emergent BioSolutions
    • Catalent
    • Vaxcyte
    • Samsung Biologics
    • Pfizer CentreOne
    • WuXi Biologics
    • Boehringer Ingelheim BioXcellence
    • Fujifilm Diosynth Biotechnologies
    • AGC Biologics
    • Rentschler Biopharma
    • Cytovance Biologics
    • Grand River Aseptic Manufacturing
    • KBI Biopharma
    • Vetter Pharma
    • Ajinomoto Co Inc.
    • CMC Biologics
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Vaccine Contract Manufacturing Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Vaccine Contract Manufacturing Market, by Vaccine Type 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Vaccine Contract Manufacturing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Vaccine Contract Manufacturing Market, by Application 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Vaccine Contract Manufacturing Market, by End User 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Vaccine Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Vaccine Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2030
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product Type segment market share analysis, 2023 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Europe Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Asia Pacific Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Latin America Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Germany Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE India Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Philippines Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Brazil Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Saudi Arabia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV3083

REPORT HIGHLIGHT

Vaccine Contract Manufacturing Market size was valued at USD 2,900.10 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.

The practice of a pharmaceutical firm (the contract manufacturer) producing vaccines for another corporation, or the client is known as vaccine contract manufacturing. Through this agreement, the customer can create vaccines under their specifications and needs by utilizing the contract manufacturer's manufacturing experience, facilities, and capabilities.

Vaccine Contract Manufacturing Market- Market Dynamics

Rising demand for vaccines and the biotechnology industry are expected to propel market demand

The global demand for vaccines continues to rise due to expanding vaccination programs, increasing the prevalence of infectious diseases, and the need for new vaccines to combat emerging pathogens. This demand drives pharmaceutical companies to seek contract manufacturing partners to scale up production efficiently. Vaccine manufacturing often requires specialized facilities, technologies, and expertise. Contract manufacturers with established capabilities in vaccine production can offer efficient solutions, enabling pharmaceutical companies to focus on research, development, and distribution. Thus, advancement in research and technology is playing a vital role in market growth.

Vaccine manufacturing is highly regulated by health authorities worldwide including FDA, and EMA. Contract manufacturers with established regulatory compliance expertise can expedite the approval process and ensure adherence to quality standards, reducing time to market for new vaccines. Many pharmaceutical companies may face limitations in their internal manufacturing capacities. Contract manufacturers provide additional capacity, flexibility, and scalability to meet fluctuating demand and supply vaccines globally. Therefore, to enhance manufacturing capabilities, vaccine contract manufacturing complements the market growth with changing demands.

Vaccine Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, the attenuated segment was predicted to show maximum market share in the year 2023, owing to the high prevalence of viral illness.

Based on Product Type segmentation, the single vaccine segment was predicted to show maximum market share in the year 2023, owing to high monovalent vaccine types.

Based on Application segmentation, the human use segment was the leading Application in 2023, owing to the rising demand for vaccination among humans.

Based on End User segmentation, pharmaceutical companies' segment was the leading End User in 2023, owing to a high number of ongoing developments in pharma companies for vaccine manufacturing.

On the basis of region, North America was the leading revenue generator in 2023, owing to the presence of top market players.

Vaccine Contract Manufacturing Market- Segmentation Analysis:

The Global Vaccine Contract Manufacturing Market is segmented on the basis of Vaccine Type, Product Type, Application, End User, and Region.

The market is divided into four categories based on Vaccine Type: attenuated, inactivated, DNA-based, and toxoid-based. The attenuated vaccine segment dominates the market. High demand for viral infections is boosting the demand for attenuated vaccines.

The market is divided into two categories based on Product Type: single vaccine and combination vaccine. The single vaccine segment dominates the market. Combination vaccine is anticipated to grow at the highest rate during the forecast period.

The market is divided into two categories based on the Application: human use and veterinary. The human use segment dominates the market. The rising need for vaccination in human beings to avoid and pre-immune against viral & severe diseases is augmenting segment demand.

The market is divided into three categories based on End User: biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing number of vaccines need & manufacturing at biopharma companies is fueling market growth.

Vaccine Contract Manufacturing Market- Geographical Insights

Worldwide, the Vaccine Contract Manufacturing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The Asia-Pacific region is witnessing rapid growth in vaccine contract manufacturing, driven by lower production costs, growing biopharmaceutical industry, and increasing investments in healthcare infrastructure. Countries like India and China are becoming key players in global vaccine supply chains, offering competitive advantages in cost-effective manufacturing and large-scale production capabilities.

Vaccine Contract Manufacturing Market- Competitive Landscape:

The market for Vaccine Contract Manufacturing is characterized by stiff competition among few key companies. Several prominent contract manufacturing organizations (CMOs) dominate the market include Lonza, Catalent, Samsung Biologics, etc. These players in the vaccine contract manufacturing market are continuously expanding their production capacities to meet increasing demand. Companies are investing in advanced biotechnological platforms and manufacturing technologies to improve vaccine production efficiency and yield.

Recent Developments:

In October 2023, Vaxcyte and Lonza Group collaborated for global commercial manufacturing of broad-spectrum Pneumococcal Conjugate Vaccines (PCVs).

In December 2023, Ajinomoto Co., Inc. bought All Forge Biologics Holdings, LLC shares. The facility was targeted to boost production abilities for manufacturing biologics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Lonza Group
  • Emergent BioSolutions
  • Catalent
  • Vaxcyte
  • Samsung Biologics
  • Pfizer CentreOne
  • WuXi Biologics
  • Boehringer Ingelheim BioXcellence
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics
  • Rentschler Biopharma
  • Cytovance Biologics
  • Grand River Aseptic Manufacturing
  • KBI Biopharma
  • Vetter Pharma
  • Ajinomoto Co Inc.
  • CMC Biologics
  • Others

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Attenuated
  • Inactivated
  • DNA-based
  • Toxoid-based

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Single vaccine
  • Combination vaccine

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Human Use
  • Veterinary

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • Research Laboratories
  • Others

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Contract Manufacturing Market Snippet by Vaccine Type
    • 2.1.2. Vaccine Contract Manufacturing Market Snippet by Product Type
    • 2.1.3. Vaccine Contract Manufacturing Market Snippet by Application
    • 2.1.4. Vaccine Contract Manufacturing Market Snippet by End User
    • 2.1.5. Vaccine Contract Manufacturing Market Snippet by Country
    • 2.1.6. Vaccine Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Contract Manufacturing Key Market Trends

  • 3.1. Vaccine Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Contract Manufacturing Market Opportunities
  • 3.4. Vaccine Contract Manufacturing Market Future Trends

4. Vaccine Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Vaccine Contract Manufacturing Market Landscape

  • 6.1. Vaccine Contract Manufacturing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Contract Manufacturing Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 7.1.2. Attenuated
    • 7.1.3. Inactivated
    • 7.1.4. DNA-based
    • 7.1.5. Toxoid-based

8. Vaccine Contract Manufacturing Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. Single vaccine
    • 8.1.3. Combination vaccine

9. Vaccine Contract Manufacturing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Human Use
    • 9.1.3. Veterinary

10. Vaccine Contract Manufacturing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Biopharmaceutical Companies
    • 10.1.3. Research Laboratories
    • 10.1.4. Others

11. Vaccine Contract Manufacturing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Vaccine Contract Manufacturing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Vaccine Contract Manufacturing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Vaccine Contract Manufacturing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Vaccine Contract Manufacturing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Vaccine Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Vaccine Contract Manufacturing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Lonza Group
    • 12.2.2. Emergent BioSolutions
    • 12.2.3. Catalent
    • 12.2.4. Vaxcyte
    • 12.2.5. Samsung Biologics
    • 12.2.6. Pfizer CentreOne
    • 12.2.7. WuXi Biologics
    • 12.2.8. Boehringer Ingelheim BioXcellence
    • 12.2.9. Fujifilm Diosynth Biotechnologies
    • 12.2.10. AGC Biologics
    • 12.2.11. Rentschler Biopharma
    • 12.2.12. Cytovance Biologics
    • 12.2.13. Grand River Aseptic Manufacturing
    • 12.2.14. KBI Biopharma
    • 12.2.15. Vetter Pharma
    • 12.2.16. Ajinomoto Co Inc.
    • 12.2.17. CMC Biologics
    • 12.2.18. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us